Farallon Capital Management: Stock Portfolio, Performance and Latest Trades
13F portfolio value
$21.7B
89 holdings at Q2 2026
Get an email when Farallon Capital Management files a new 13F report
Free, no account needed. Unsubscribe with one click.
Farallon Capital Management's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 14.9% | $34.94 | +438% | $188.12 | Reduced −0.4% | |
Electronic Arts Inc.285512109 | 9.51% | $204.23 | — | — | Added +6.0% |
| 4.68% | $40.03 | +62.5% | $65.04 | Added +15% | |
| 4.56% | $20.91 | +569% | $139.91 | No change | |
Exelixis Inc.EXEL | 4.29% | $22.85 | +158% | $59.02 | Added +2.7% |
Liquidia Corp.LQDA | 3.90% | $17.60 | +59.2% | $28.02 | Reduced −3.4% |
Amazon.com Inc.AMZN | 3.67% | $207.70 | +22.3% | $254.06 | Reduced −38% |
| 3.63% | $75.96 | +31.8% | $100.12 | No change | |
Natera Inc.NTRA | 3.52% | $69.61 | +461% | $390.79 | Reduced −31% |
| 3.09% | $451.60 | −17.9% | $370.95 | Reduced −30% | |
| 3.08% | $484.70 | +34.5% | $651.98 | Added +19% | |
| 2.96% | $26.90 | +27.2% | $34.21 | Added +48% | |
| 2.68% | $331.14 | −16.3% | $277.12 | Reduced −45% | |
| 2.63% | $68.60 | −38.7% | $42.04 | Added +41% | |
Broadcom Inc.AVGO | 2.55% | $343.37 | +4.9% | $360.14 | Reduced −35% |
Microsoft Corp.MSFT | 2.43% | $355.62 | +47.0% | $522.61 | Reduced −53% |
| 2.25% | $9.92 | +128% | $22.57 | Added +35% | |
| 2.21% | $113.60 | −21.2% | $89.56 | Reduced −12% | |
Synopsys Inc.SNPS | 2.17% | $445.61 | +11.7% | $497.75 | Reduced −32% |
| 2.06% | $39.95 | −38.4% | $24.60 | Added +1.0% | |
Crinetics Pharmaceuticals In22663K107 | 1.97% | $44.54 | — | — | Added +7.8% |
Grail Inc.GRAL | 1.66% | $56.93 | +133% | $132.61 | Added +28% |
Wabtec Corp.WAB | 1.41% | $146.34 | +91.9% | $280.80 | Reduced −44% |
Immunovant Inc.IMVT | 1.31% | $29.25 | +3.4% | $30.26 | Added +275% |
| 1.29% | $51.54 | +195% | $152.05 | Added +50% | |
| 1.29% | $28.88 | +10.5% | $31.92 | Added +4.1% | |
AramarkARMK | 1.21% | $33.85 | +64.1% | $55.54 | Reduced −41% |
| 0.81% | $120.83 | −30.5% | $83.92 | Added +171% | |
| 0.73% | $44.28 | −13.8% | $38.18 | Added +235% | |
| 0.73% | $22.56 | +26.2% | $28.48 | Added +143% | |
| 0.71% | $40.92 | +55.6% | $63.66 | Added +7.2% | |
| 0.64% | $189.95 | −16.4% | $158.78 | Added +153% | |
| 0.61% | $233.01 | +10.1% | $256.48 | Added +176% | |
Strategy Inc.Bond594972AS0 | 0.44% | — | — | — | Added +122% |
| 0.38% | $27.37 | +2.6% | $28.09 | New | |
| 0.33% | $149.91 | −4.5% | $143.11 | New | |
| 0.28% | $108.20 | +53.0% | $165.56 | Added +3928% | |
Vnet Group Inc.Bond90138AAE3 | 0.27% | — | — | — | No change |
| 0.27% | $15.74 | −14.7% | $13.43 | Added +173% | |
Joyy Inc-AdrJOYY | 0.27% | $47.94 | +68.6% | $80.85 | Added +21% |
| 0.26% | $23.18 | −1.6% | $22.82 | Added +31% | |
| 0.21% | $39.82 | −69.6% | $12.10 | Reduced −16% | |
| 0.19% | $32.24 | −19.7% | $25.88 | Added +197% | |
| 0.15% | $115.45 | +23.3% | $142.38 | Reduced −45% | |
| 0.15% | $24.76 | +0.8% | $24.95 | New | |
Freenome Inc.FRNM | 0.14% | $11.28 | +40.2% | $15.81 | No change |
| 0.14% | $21.98 | −54.5% | $10.00 | New | |
| 0.10% | $98.39 | −5.1% | $93.34 | Added +241% | |
| 0.10% | $30.08 | +9.1% | $32.81 | New | |
Abivax Sa-AdrABVX | 0.10% | $132.47 | −32.8% | $89.05 | Added +6000% |
Vnet Group Inc.VNET | 0.09% | $8.80 | −41.3% | $5.17 | Added +220% |
Netease Inc-AdrNTES | 0.09% | $124.07 | −3.6% | $119.60 | Reduced −58% |
Biogen Inc.BIIB | 0.09% | $191.29 | +14.2% | $218.43 | New |
| 0.09% | $5.92 | −25.1% | $4.43 | New | |
| 0.09% | $12.95 | −33.9% | $8.56 | New | |
Strategy Inc.Bond594972AN1 | 0.08% | — | — | — | New |
| 0.08% | $4.02 | −19.9% | $3.22 | No change | |
| 0.07% | $22.63 | +14.5% | $25.91 | New | |
Alvotech SAALVO | 0.06% | $4.13 | +37.1% | $5.67 | Added +1332% |
| 0.05% | $17.71 | −1.6% | $17.43 | Reduced −84% | |
Inflarx NVIFRX | 0.04% | $1.88 | −18.6% | $1.53 | New |
| 0.04% | $61.94 | −18.6% | $50.43 | New | |
| 0.03% | $21.03 | +25.9% | $26.48 | New | |
| 0.03% | $80.16 | −22.2% | $62.35 | New | |
Gentex Corp.GNTX | 0.03% | $23.65 | −10.6% | $21.15 | New |
| 0.03% | $560.90 | −8.5% | $513.14 | New | |
| 0.03% | $4.62 | −22.5% | $3.58 | No change | |
| 0.02% | $70.32 | −10.3% | $63.10 | New | |
| 0.02% | $10.63 | −0.7% | $10.56 | New | |
| 0.02% | $6.80 | +31.2% | $8.92 | New | |
Strategy Inc.Bond594972AU5 | 0.01% | — | — | — | New |
| 0.01% | $36.10 | −9.4% | $32.69 | No change | |
| 0.01% | $30.52 | +28.6% | $39.25 | Reduced −89% | |
| 0.01% | $0.33 | +2761% | $9.44 | No change | |
| 0.00% | $6.41 | +369% | $30.08 | No change | |
Aleanna Inc.ANNAW | 0.00% | $0.14 | +78.6% | $0.25 | No change |
Aleanna Inc.ANNA | 0.00% | $0.9536 | +167% | $2.55 | No change |
Welltower Inc.WELL | 0.00% | $186.78 | +19.4% | $223.04 | Reduced −100% |
| 0.00% | $2.29 | — | — | No change | |
Blue Gold Ltd.BGLWW | 0.00% | $0.4682 | −92.0% | $0.0375 | Reduced −15% |
| 0.00% | $10.13 | −77.3% | $2.30 | Reduced −89% | |
Geron Corp.GERN | 0.00% | $3.63 | −66.4% | $1.22 | Reduced −67% |
Nvni Group Ltd-28NVNIW | 0.00% | $0.0355 | −71.3% | $0.0102 | No change |
| 0.00% | $6.45 | −86.9% | $0.847 | Reduced −40% | |
| 0.00% | $1.35 | −41.3% | $0.792 | Reduced −73% | |
Beyond Meat Inc.08862E109 | 0.00% | $3.49 | — | — | No change |
Farallon Capital Management's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $4.5B | New | |
| Put · bet on a fall or hedge | $83.3M | New | |
CG Oncology Inc.CGON | Call · bet on a rise | $28.4M | New |
CG Oncology Inc.156944900 | Call · bet on a rise | — | Sold out |
Invesco S&P 500 Equal Weight46137V957 | Put · bet on a fall or hedge | — | Sold out |
SS Spdr S&P 500 ETF Trust-Us78462F953 | Put · bet on a fall or hedge | — | Sold out |
Farallon Capital Management's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
| Added +42% | +3,640,000 | $5.9B | |
Activision Blizzard Inc.00507V109 | Sold out | −20,320,000 | — |
Vmware Inc-Class A928563402 | Sold out | −5,498,500 | — |
Horizon Therapeutics PLCG46188101 | Sold out | −6,656,823 | — |
Pioneer Natural Resources Co.723787107 | New | +3,120,000 | $701.6M |
Seagen Inc.81181C104 | Sold out | −2,270,500 | — |
Hess Corp.HES | New | +2,975,000 | $428.9M |
Nasdaq Inc.NDAQ | Added +6310% | +6,468,000 | $382M |
| Sold out | −665,661 | — | |
| Reduced −28% | −312,200 | $310.6M | |
Anthem Inc.ELV | Sold out | −381,330 | — |
Karuna Therapeutics Inc.48576A100 | Added +23627% | +519,800 | $165.2M |
Splunk Inc.848637104 | Added +387% | +1,052,375 | $201.7M |
Wabtec Corp.WAB | Added +21% | +682,261 | $499.8M |
Astrazeneca Plc-Spons ADR046353108 | Reduced −37% | −2,235,262 | $257.6M |
| Added +7.0% | +194,700 | $685.1M | |
| Added +19% | +1,512,000 | $464.3M | |
Masimo Corp.574795100 | Added +476% | +1,084,000 | $153.7M |
Humana Inc.HUM | Reduced −67% | −243,117 | $55.6M |
Natera Inc.NTRA | Added +53% | +1,197,000 | $217.7M |
Vestis Corp.VSTS | New | +5,469,753 | $115.6M |
| Added +15% | +155,600 | $638.6M | |
| Sold out | −366,000 | — | |
| New | +476,000 | $104.7M | |
Block Inc.XYZ | Sold out | −2,336,350 | — |
| Added +103% | +3,411,374 | $193.2M | |
United States Steel Corp.912909108 | Added +286% | +1,814,500 | $119.2M |
| Reduced −87% | −1,385,173 | $13.2M | |
| Added +4896% | +1,066,000 | $90.8M | |
| Added +101% | +429,000 | $174M | |
Microsoft Corp.MSFT | Reduced −0.8% | −10,600 | $503.4M |
PDD Holdings Inc.Bond722304AC6 | Sold out | −76,510,000 | — |
Mirati Therapeutics Inc.60468T105 | Added +102% | +1,023,472 | $118.9M |
Exelixis Inc.EXEL | Added +3.0% | +774,500 | $639M |
| Added +15% | +781,000 | $336.5M | |
Catalent Inc.148806102 | New | +1,413,000 | $63.5M |
| Reduced −6.1% | −274,388 | $395.3M | |
| Added +12% | +334,500 | $272.8M | |
AramarkARMK | Added +39% | +4,763,054 | $474.9M |
Dexcom Inc.DXCM | Sold out | −544,000 | — |
| Reduced −12% | −165,127 | $116.7M | |
Intuit Inc.INTU | Reduced −4.2% | −23,100 | $333.1M |
| Reduced −73% | −147,000 | $22.4M | |
| Reduced −11% | −144,100 | $633.1M | |
| Added +114% | +828,020 | $78.7M | |
| Reduced −23% | −452,900 | $295.7M | |
Denbury Inc.24790A101 | Sold out | −425,000 | — |
| Reduced −84% | −375,602 | $9.5M | |
| Added +5.3% | +288,000 | $131.5M | |
| Reduced −64% | −655,158 | $28.3M | |
| Reduced −76% | −798,500 | $15.1M | |
Cazoo Group Ltd.Bond14986TAA3 | Sold out | −100,000,000 | — |
| Added +90% | +3,482,600 | $82.4M | |
| Reduced −88% | −153,500 | $5.7M | |
Zto Express Cayman Inc-AdrBond98980AAB1 | Added +114% | +40,000,000 | $70.2M |
TransunionTRU | Reduced −1.2% | −110,300 | $626.8M |
| Reduced −0.7% | −31,600 | $255.2M | |
Cencora Inc.COR | New | +169,000 | $34.7M |
| Reduced −38% | −327,233 | $41.5M | |
| Added +4.8% | +36,700 | $207.8M | |
| Reduced −12% | −56,300 | $297.6M | |
| Reduced −99% | −144,000 | $472.8K | |
PG&E Corp.PCG | Reduced −46% | −1,950,000 | $41M |
Alphabet Inc.GOOG | Reduced −12% | −418,600 | $442.3M |
Amedisys Inc.AMED | Added +62% | +262,000 | $65.2M |
Immunogen Inc.45253H101 | New | +842,000 | $25M |
| Added +52% | +1,416,773 | $92.8M | |
| Reduced −39% | −4,032,750 | $60.7M | |
| Added +2.1% | +13,000 | $264.2M | |
Cerevel Therapeutics Holding15678U128 | New | +567,321 | $24.1M |
S&P Global Inc.SPGI | Reduced −12% | −116,800 | $388.8M |
Splunk Inc.Bond848637AF1 | New | +23,500,000 | $22.9M |
| Added +14% | +263,000 | $71.5M | |
Sdcl Edge Acquisition Corp.G79471101 | Sold out | −1,732,500 | — |
| Reduced −24% | −529,700 | $222.2M | |
National Instruments Corp.636518102 | Sold out | −265,000 | — |
Ares Acquisition CorporationG33032106 | Sold out | −1,425,000 | — |
Earthstone Energy Inc. - A27032D304 | Sold out | −618,831 | — |
Savara Inc.SVRA | Reduced −43% | −4,652,680 | $29.4M |
Chindata Group Holdings-Adr16955F107 | Sold out | −1,300,000 | — |
Sovos Brands Inc.84612U107 | New | +418,000 | $9.2M |
Sunrun Inc.Bond86771WAB1 | Added +5.1% | +6,000,000 | $93.9M |
| Reduced −34% | −294,200 | $19.1M | |
| Reduced −97% | −121,653 | $318.4K | |
| Reduced −21% | −214,700 | $259.5M | |
| Added +303% | +822,483 | $9.8M | |
Apellis Pharmaceuticals03753U106 | Reduced −97% | −188,053 | $359.2K |
Cazoo Group Ltd.CZOOF | New | +714,240 | $6.8M |
Crinetics Pharmaceuticals In22663K107 | Reduced −66% | −239,000 | $4.4M |
Slam Corp.SLAMF | Sold out | −570,396 | — |
Zymeworks Inc.ZYME | Reduced −12% | −244,000 | $18.2M |
| Reduced −24% | −599,900 | $506.7M | |
Quanterix Corp.QTRX | New | +184,000 | $5M |
Immunovant Inc.IMVT | Reduced −32% | −163,000 | $14.4M |
Soleno Therapeutics Inc.834203309 | Reduced −57% | −222,781 | $6.7M |
| New | +562,000 | $4.6M | |
Forest Road Acquisition Cor34619V103 | Sold out | −400,000 | — |
| Reduced −8.4% | −376,086 | $111.8M | |
Verve Therapeutics Inc.92539P101 | Sold out | −211,293 | — |
Bluebird Bio Inc.09609G100 | New | +2,000,000 | $2.8M |
| Added +8.0% | +150,000 | $19.1M | |
Cara Therapeutics Inc.140755109 | Reduced −6.6% | −110,340 | $1.2M |
Oklo Inc.OKLO | Sold out | −98,300 | — |
Lufax Holding Ltd-Adr54975P102 | Sold out | −600,000 | — |
| Reduced −7.0% | −313,000 | $306.6M | |
| New | +149,999 | $460.5K | |
| New | +34,000 | $382.5K | |
| New | +6,000 | $242.2K | |
Arcellx Inc.03940C100 | New | +4,000 | $222K |
Bruker Corp.BRKR | New | +3,000 | $220.4K |
| New | +2,800 | $217.7K | |
| New | +10,000 | $216.1K | |
Vaxcyte Inc.PCVX | New | +3,400 | $213.5K |
Glaukos Corp.GKOS | New | +2,600 | $206.7K |
| New | +3,400 | $205.3K | |
| Sold out | −2,800 | — | |
Akero Therapeutics Inc.00973Y108 | Sold out | −4,000 | — |
| New | +4,600 | $200.3K | |
| New | +14,000 | $199.8K | |
Ares Acquisition CorporationG33032122 | Sold out | −200,000 | — |
Mercato Partners Acquisition Corp.58759A116 | Sold out | −375,000 | — |
Nabors Energy Transition Corp.629567116 | Sold out | −450,000 | — |
| New | +450,000 | $56.3K | |
| New | +120,085 | $39.6K | |
Disruptive Acquisition Corp.G2770Y128 | Sold out | −466,667 | — |
Nvni Group Ltd-28NVNIW | New | +375,000 | $13.3K |
Churchill Capital Corp. Vi17143W119 | Sold out | −80,000 | — |
Apollo Strategic Grwt Cptl IG0412A128 | Sold out | −150,000 | — |
R1 RCM Inc.77634L105 | Added +33% | +4,000 | $169.1K |
Thunder Bridge Cap Prtnrs II88605T118 | Sold out | −150,000 | — |
Finserv Acquisition Corp. II31809Y111 | Sold out | −150,000 | — |
Forest Road Acquisition Cor34619V111 | Sold out | −250,000 | — |
Eqrx Inc.26886C115 | Sold out | −120,085 | — |
Getaround Inc.37427G119 | Sold out | −80,000 | — |
Farallon Capital Management's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 62% |
| Technology | 12% |
| Other | 12% |
| Financials | 8.1% |
| Consumer Discretionary | 5.0% |
| Industrials | 1.5% |
| Materials | 0.3% |
| Energy | 0.0% |
| Real Estate | 0.0% |
Portfolio performance: Farallon Capital Management vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +56.8% | +9.4% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 56% of the portfolio value on average; the rest is left out of the return.
Farallon Capital Management's most traded stocks
Quarters with a buy or a sell, all reports since Q2 2013.
| Company | Quarters bought | Quarters sold |
|---|---|---|
Microsoft Corp.MSFT | 25 | 27 |
Alphabet Inc.GOOG | 19 | 24 |
| 19 | 22 | |
Wabtec Corp.WAB | 20 | 18 |
Exelixis Inc.EXEL | 21 | 16 |
TransunionTRU | 15 | 20 |
| 20 | 13 | |
| 18 | 11 | |
Grifols Sa-AdrGRFS | 14 | 14 |
| 15 | 12 | |
| 10 | 17 | |
| 15 | 11 | |
| 16 | 10 | |
| 14 | 12 | |
| 13 | 12 |